Press Releases

Global Market for Nucleic Acid Aptamers to Reach $5.4 Billion in 2019, Overall Market Surging With 73.5% CAGR

November 25, 2014

Wellesley, Mass., November 18, 2014 – The high affinity and specificity of nucleic acid aptamers is driving global demand with the market expected to grow to $340.5 million by the end of 2014 and to about $610.3 million in 2015. This should further reach nearly $5.4 billion by 2019, with a compound annual growth rate (CAGR) of 73.5% from 2014 to 2019.

An increasing number of applications for aptamers in diagnostics, therapeutics and research, along with technological advancements, are the driving factors of this market. With most of the research activities being conducted in the United States, it is no surprise that the North America region dominates the market globally. This is due to favorable government policies for conducting clinical trials and research which are, in turn, fuelling market growth.

“Nucleic acid aptamers exhibit enhanced effectiveness, and have a low manufacturing cost. This makes them ideal for the treatment of diseases such as HIV/AIDS, cancer and other autoimmune diseases,” says BCC Research analyst Yojana Jeevane.

European countries, on the other hand, are the least involved in this market due to unfavorable government regulations which discourage the adoption of aptamer-based applications. Furthermore, the nucleic acid aptamer market in developing countries such as India and China in the Asia-Pacific region are facing challenges due to stringent government regulations and poor response from society because of ethical issues.

Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets presents an in-depth analysis of the global nucleic acid aptamer market by technologies, applications and geographic regional markets. The evolving trends and technological developments in the field of aptamers have been studied in detail.


To Contact us, click here  

Source: BCC Research

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at


Nucleic Acid Aptamers for Diagnostics and Therapeutics: Global Markets( BIO071C )
Publish Date:     

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.